Anticoagulant and Antiplatelet Prescribing Patterns for Patients with Atrial Fibrillation after Percutaneous Coronary Intervention

BACKGROUND: Current guidelines recommend triple antithrombotic therapy (TAT), defined as acetylsalicylic acid (ASA), clopidogrel, and warfarin, for patients with nonvalvular atrial fibrillation who have undergone percutaneous coronary intervention with stent implantation. The choice of anticoagulant...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Can J Hosp Pharm
Päätekijät: Woods, Erin A, Ackman, Margaret L, Graham, Michelle M, Koshman, Sheri L, Boswell, Rosaleen M, Barry, Arden R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Canadian Society of Hospital Pharmacists 2016
Aiheet:
Original Research / Recherche Originale
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008423/
https://ncbi.nlm.nih.gov/pubmed/27621487
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia